SECUADO — 1911557
Application number
1911557
Registration number
TMA1103441
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2018-07-25
Registered
2021-07-07
Registration Expiry Date
2031-07-07
Registered Owner
Hisamitsu Pharmaceutical Co., Inc.
408, Tashirodaikan-machi
Tosu-shi, Saga 841-0017
JAPAN
Agent
BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9
Documents
Index headings
- SECUADO
Goods (Nice class & Statement)
- 5
- (1) Medicated transdermal patches, plasters, cataplasms, gels, creams and sprays for the relief of aches and pains of muscles and joints associated with arthritis, simple backaches, strains, bruises and sprains; antiinflammatory and analgesic agents; Gauze for dressings; Capsules sold empty for pharmaceuticals; Eyepatches for medical purposes; Ear bandages; Menstruation bandages; Menstruation tampons; Sanitary napkins; Absorbent cotton; Cotton wool for medical purposes; Adhesive plasters, namely, adhesive bandages, surgical adhesives, medical plasters; Bandages for dressings; Liquid dressings, namely, burn dressings, medical and surgical dressings, self-adhesive dressings, wadding for wound dressing, wound dressings; Breast-nursing pads, breast-nursing padding, breast pads, breast shields; Wound dressings; Diapers, namely baby diapers, incontinence diapers, cloth diapers, disposable diapers; Dietary supplements for humans, namely, dietary supplements for general health and well-being; Dietetic beverages adapted for medical purposes, namely, herbal beverages for medicinal purposes, namely energy drinks for general health and well-being; Pharmaceutical preparations, namely, antihistamines and decongestants; Pharmaceutical antipsychotic preparations; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, Parkinson's disease, and schizophrenia; pharmaceutical preparations for the treatment of schizophrenia.
Claims
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2018-07-25 | ||
| Created | 2018-07-26 | ||
| Formalized | 2018-07-30 | ||
| Search Recorded | 2020-07-23 | ||
| Examiner's First Report | 2020-07-23 | 2021-01-23 | |
| Approved | 2021-02-02 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2021-02-02 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2021-03-03 | Vol.68 Issue 3462 | |
| Registration Pending | 2021-05-26 | ||
| Registration Fee Notice Sent | 2021-05-26 | 2021-11-26 | |
| Registered | 2021-07-07 | 2031-07-07 |